-+ 0.00%
-+ 0.00%
-+ 0.00%

IRONWOOD PHARMACEUTICALS REITERATES FULL-YEAR 2025 LINZESS U.S. NET SALES GUIDANCE AND RAISES ADJUSTED EBITDA GUIDANCE

Reuters·04/25/2025 11:05:00

Please log in to view news